Dermatology’s growing focus on skin longevity demands clear definitions, validated outcomes, and rigorous evidence beyond anti-aging claims.
|Articles|December 1, 2001
Foam Sclerotherapy Requires Fewer Injections
DALLAS - Although still in its infancy, foam sclerotherapy is a promising new treatment technique for telangiectatic, reticular, and varicose leg veins and has the potential to achieve higher rates of resolution with fewer injections compared with conventional sclerotherapy, Robert A. Weiss, M.D., said at the annual meeting of the American Society for Dermatologic Surgery.
Advertisement
Advertisement
Related to this article
Castor oil has become a popular social media remedy for thicker, longer hair, but evidence supporting its ability to stimulate hair growth remains limited.
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Advertisement
Advertisement
Trending on Dermatology Times
1
Lutikizumab Meets Primary End Point in Phase 3 HS Trial
2
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
3
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
4
Fall Clinical 2026: The Data and Expert Advice Shaping Dermatology Practice
5